Glycomimetics Inc (GLYC)

• $0.16

  $0.16

  $0.16
  

  0.88%

  Downside

  Day's Volatility :2.4%

  Upside

  1.54%

  
• $0.15

  $3.53

  $0.16
  

  8.56%

  Downside

  52 Weeks Volatility :95.86%

  Upside

  95.47%

  

Returns

What analysts predicted

Upside of 368.75%

• Bvf Inc

  14.80%

• Artal Group S A

  13.32%

• Vanguard Group Inc

  4.18%

• Renaissance Technologies Corp

  1.28%

• Goldman Sachs Group Inc

  1.25%

• BlackRock Inc

  1.12%

at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc.